whether Lantus increases cancer risk
Patients are asking whether Lantus increases cancer risk.
Recent European studies suggest a higher cancer risk in patients using Lantus (insulin glargine) ALONE compared to other insulins.
A Swedish study suggests one extra case of breast cancer for every 1000 women using Lantus alone for 1 year compared to other insulins.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: MD includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote